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Optimization of glycemic control is associated with a lower rate of
target lesion revascularizatiion in treated diabetic patients after drug
eluting stent implantation
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Patients with diabetes mellitus (DM) have increased rates of target lesion
revascularization (TLR) and worse clinical outcome after percutaneous coro-
nary intervention (PCI).
The use of drug eluting stents (DES) appears to largely neutralize the exag-
geration in stent neointimal proliferation. Implantation of DES reduces the rate
of TLR so dramatically that the importance of glycemic control during the
follow up appears unclear.
We sought to determine the influence of glycemic control and its dynamic
changes assessed by preprocedural glycosylated haemoglobin (HbA1c) and at
2-year follow up on rate of TLR in diabetic patients undergoing elective PCI
using DES.
Our monocentric study concerned 184 consecutive diabetic patients under-
going de novo lesions PCI using DES. Preprocedural glycemic control is
assessed by HbA1c1 value and at 2-year follow up by HbA1c2 value. Optimal
glycemic control is defined by HbA1c ≤ 7% and suboptimal glycemic control
by HbA1c> 7%.
The mean age of patients was 65±10 years, 59% were male and 44% are
insulin inquiring patients. Initial angina status was represented by acute coronary
syndrome in 56%, stable angina in 25% and silent ischemia in 19% of cases.
HbA1c1 value was available in 170 patients: 59 patients with HbA1c1 ≤7%
and 111 patients with HbA1c1>7% with a mean HBA1c1 value: 7.9% ± 1.6.
HbA1c2 value was available in 153 patients: 62 patients HbA1c2 ≤7% and 91
patients with HbA1c2 ≥7% with a mean HbA1c2 value 7.6% ± 1.4.
The results showed that only HbA1c2 ≤7% was associated with a signifi-
cantly decreased of TLR (1,7 vs 20,8, p=0,004). In multivariate analysis,
optimal glycemic treatment at long time (HbA1c 2 ≤ 7%) appeared as an inde-
pendent predictive factor of TLR free survival (p<0.001)
In conclusion, whatever the baseline glycemic control, aggressive treatment
of diabetes to achieve A1c levels ≤7% may be beneficial in reducing the rate
of TLR after DES implantation.
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Interest of systematic screening of metabolic syndrome and high car-
diovascular risk in French general healthy population
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Background: Cardiovascular disease is a leading cause of death in France;
knowledge of the importance of risk factors is an important issue.
Methods: Between May 2006 and December 2008, in coordination with
the regional health insurance fund of the Hauts-de-Seine area (CPAM 92), we
performed a systematic screening of cardiovascular risk factors and metabolic
syndrome in a population of men from 45 to 60 years old and women between
55 and 70 years old without any cardiovascular medical history.
Results: 50 000 questionnaires have been sent to residents of nine cities in
Hauts-de-seine area. Answering selection questionnaires rate is about 22%
(10764 persons). 8038 participants were enrolled in our study. 4 081 men (54
years old middle-age) and 4 227 women (62 years old middle-age) have been
included. Among this population, 2000 (20%) persons have a medical history
of hypertension (not well balanced for 51% of them), 1716 have an unknown
hypertension. 20% of participants has a known dyslipidemia (not well bal-
anced: 16%) and 1679 an unknown dyslipidemia (22%). 685 (8,5%) persons
have a medical history of diabetes (not well balanced for 52% of them) and
218 an unknown one. Smokers represents 21% oh this population, more fre-
quently men (28%) than women (13%). Abdominal obesity prevalence is very
high representing in our study 3 100 persons (38%) and affects women (51%)
more often than men (24%). Metabolic syndrome concerns 15% of the patients
(17% of men, 13% of women). Sleepiness on the Epworth sleepiness scale
represents 9%. After global cardiovascular risk assessment, 732 (9%) persons
were classified at high risk of cardiovascular events, 2600 (33%) persons at
moderate risk and 4700 (58%) at lower risk.
Conclusion: According to the important prevalence of patients with a high
risk of cardiovascular events, our study demonstrates the interest of a system-
atic primary screening in a French healthy population.
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Efficacy of a global atherosclerosis management on the reduction of
cardiovascular risk and events after an ischemic stroke
Marianne Lafitte (1), Annabel Kazadi (2), Igor Sibon (2), François Roua-
net (2), Thierry Couffinhal (1)
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Background: After an ischemic stroke, the risk of cardiovascular (CV)
event is high. The effect of optimal control of risk factors on this high morbi-
mortality has not been established in these patients.
Aim: To evaluate the effect of optimized secondary prevention including
dietetic and therapeutic education, on CV risk factor control and CV events
occurrence.
Patients and method:95 selected consecutive patients at high CV risk pro-
file (>3 CVRF) benefited from a 2 days hospitalization 3 months after a stroke
focused on evaluating risk factors and atherosclerosis lesions, and on opti-
mizing treatment and education.
Results: In this high risk population (mean age 60.4±8), we found respec-
tively 24% and 23% of the patients with previously unknown peripheral vas-
cular disease or coronaropathy, and 31% with left ventricular hypertrophy. At
follow-up (median 684 days), 81% of the patients still received a combination
of antiagregant + blood pressure drugs + statin. In term of secondary preven-
tion goals, 73% of the patients had a normal blood pressure, 72% had a LDL
<1g/l, 84% of the diabetics had HbA1c< 7%. 53% of the subjects practiced
recommended physical activity. 24% still smoked.
Conclusion: A global atherosclerosis management and educational pro-
gram of high-risk patients following stroke is beneficial for the long-term con-
trol of cardiovascular risk factors and the sustainability of drug treatments. 
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The value of metabolic syndrome (Mets) in the identification of high car-
diovascular risk subjects remains questionable.
We sought to examine the association among Mets and the occurrence of a
coronary heart disease (CHD).
Methods: Between 2006 and 2008, 540 patients were screened for the
Mets according to the NCEP-ATP III definition. The mean age was 61 ± 12.3
 Study REACH France population
Cardiovascular deaths 0 1,7%
Major CV events 7,6% 10,3%
Minor CV events 10,0% 15,3%
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years, 63.3 % were men. Mets was diagnosed in 60% of the population. 276
had CHD confirmed by angiocoronarography (51,1%).
Results: Patients characteristics are presented in the table. 
CHD (+) patients had a higher prevalence of metabolic syndrome: 74,6%
versus 44,7% (p=0.05). Multivariate analyses revealed that only Mets was sig-
nificantly associated with CHD (OR: 1.48 95% CI: 1.10-2.4, p=0.05).
Conclusion: Our study indicates that MetS is highly prevalent and that it
seems to be correlated to CHD.
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HIV + patients have seen their survival improve with the emergence of
poly antiviral therapies. However, it was recently shown that these therapies
had an impact on lipid metabolism. We therefore wanted to determine what
could be the impact of cardiological care systematically in this population.
Methodology: We have systematically proposed to all HIV + patients to
go to a cardiological consultation followed by biological analysis, echocardio-
graphy, cervical Doppler with intima media measurement. Depending on the
clinical and biological data it was then proposed diagnostic tests as arterial
doppler of lower limbs and stress test. We then compared these data with those
of literature studies on comparable populations in terms of age and sex.
Results: Of 97 patients regularly followed 77 were seen in consultation.
The average age of our cohort was 49.05 5 years. 74% are active smoking on
average at 15 PY, 54% are overweight (77.7 kg to 1.71 cm on average). The
hip measurement is 97.3 cm. 15% have clinical lipodystrophies. 32% have
hypertension (defined as PA> 140/95 on two occasions). 67% had dyslipi-
demia. The intima media thickness is 0.81 (Left) and right 0.82 mm for a stan-
dard 0.73 mm in our test cohort (p <0.05) and 0.75 mm as the threshold cut
off in Canadian studies (p <0.05 ). The echocardiography proved normal in
80% of patients and in 100% of patients with BNP levels <30 pg / ml. After
one year follow-up we found a lower limbs arteriopathy in 13% and an
ischemic heart disease in 11% of patients which is significantly higher than
expected and reported in literature.
In conclusion: It seems appropriate to be able to propose to HIV +
patients a cardiovascular consultation in view of their specific risk profile,
due to a non detection of almost 24% of patients with atherosclerosis and
of the increase of intima media size. However, echocardiography should
not be systematic.
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Subsequent studies have shown that metabolic syndrome (MetS) defined
using the Adult Treatment Panel III (ATP-III) imparts an increased risk of
type 2 diabetes mellitus as well as clinical and subclinical coronary artery dis-
ease (CAD) in older populations. Because the prevalence of MetS is increasing
alarmingly among adolescents and young adults, it is important to quantify its
relation with clinical CAD occurring early in life.
Aim: We sought to examine the association between MetS and early-onset
CAD.
Methods: Between January 2006 and January 2008 we performed a case-
control study with 40 early-onset CAD subjects (acute myocardial infarction,
angina with ≥ 50% stenosis, or coronary revascularization) in men under age
46 years or women under age 56 years and 60 control subjects matched for
gender and age.
Results: The population was composed by 44 men, median age was 41 years.
Different components of Mets were compared for both cases (40 subjects) and
control (60 subjects). Blood systolic and diastolic pressure were respectively 129
± 24 mmHg vs 124 ± 23 mmHg and 76.1 ± 11.4 vs 74.4 ± 12.8 mmHg (p=0.5).
Waist circumference was lower in controls with 92 ± 15 cm vs 100.6 ± 12 cm for
the cases (p=0.05). HDL cholesterol tend to be higher in controls with 1.19 ± 0.4
mmol/l vs 1.06 ± 0.8 mmol/l (p=0.4). Triglyceride and fasting glycemia were sig-
nificantly higher in cases with respectively 2.3 ± 1.5 vs 1.34 ± 0.8 mmol/l, and
9.7± 6 vs 6.5 ± 3.4 mmol/l (p ≤ 0.05). Mets was consequently higher in cases,
actually 66.7% of the cases had Mets vs 25.7% in controls. (p < 0.001).
Conclusions: Presence of MetS was higher in young patients with CAD, a
better physical activity and dietary patterns are necessary to prevent this syn-
drome as it’s related to high coronary risk.
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Interventional cardiologists are repeatedly and acutely exposed to scattered
ionizing radiations (X-rays) during their diagnostic or therapeutic procedures.
These exposures may cause damages to the eye and induce early lens-opaci-
ties, known as radiation-induced cataracts.
The O’CLOC study (Occupational Cataracts and Lens Opacities among
Cardiologists) is the first epidemiological study designed to test the hypothesis
of an increased risk of cataracts among interventional cardiologists as com-
pared with cardiologists not exposed to X-rays.
This multicenter crosss-sectional study will include a total of 300 cardiol-
ogists aged > 40 years: a group of interventional cardiologists (≈ 2/3 coronary
interventionists and 1/3 electrophysiologists) and a group of unexposed cardi-
ologists (clinicians or echocardiographists), both groups being matched for
age, sex and place of work. Individual information, including risk factors of






Age (years) 62 ± 10,2 60 ± 15,2 < 0,05
Men 75,4% 50,8% < 0,05
Smokers 48,9% 24,2% < 0,05
BMI (kg/m2) 28,5 ± 4,6 28,3 ± 6,5 < 0,05
Waist (cm) 100,2 ± 12,6 98 ± 14 0,08
SBP (mmHg) 133 ± 20,2 132 ± 24,2  0,06
Diabetes 52,9% 23,1% < 0,05
Hypertension 52,8% 46% < 0,05
TG (mmol/l) 1,96 ± 1,1 1,63 ± 1 < 0,05
HDLc (mmol/l) 1,06 ± 0,5 1,2 ± 0,5 < 0,05
